Octreotide Impurity 4 is a defined analogue that differs subtly from octreotide in residue composition or cyclization pattern. Such changes modify conformation, polarity, and chromatographic characteristics. Researchers use it as a marker in impurity panels and degradation studies. Applications include analytical-method validation, process monitoring, and structure-stability correlations.
CAT No: R2761
Synonyms/Alias:(4R,7S,10S,13S,16R)-16-((R)-2-Amino-3-phenylpropanamido)-10-(4-aminobutyl)-13-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraazacycloheptadecane-4-carboxamide
Octreotide Impurity 4 is a synthetic peptide derivative structurally related to octreotide, a well-characterized somatostatin analog. As a defined impurity, it represents a specific sequence variant or degradation product that can arise during the synthesis, formulation, or storage of octreotide. The presence and characterization of such impurities are of significant interest in peptide chemistry and pharmaceutical development, offering insights into synthetic fidelity, stability, and the overall quality of peptide-based compounds. Octreotide Impurity 4 serves as a critical reference standard and research tool for method validation, impurity profiling, and the study of peptide degradation pathways.
Analytical method development: In peptide pharmaceutical research, the availability of Octreotide Impurity 4 enables the rigorous development and optimization of analytical methods such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS). By serving as a known reference compound, it allows researchers to establish retention times, fragmentation patterns, and detection limits specific to this impurity. This facilitates the accurate quantification and identification of structurally related byproducts in octreotide formulations, ensuring robust impurity profiling and supporting regulatory compliance in quality control laboratories.
Impurity profiling and characterization: The use of Octreotide Impurity 4 is essential for comprehensive impurity profiling during the manufacturing and quality assessment of octreotide and related peptides. By incorporating this impurity into analytical workflows, scientists can assess the presence and concentration of specific sequence variants or degradation products. Such characterization is crucial for understanding the synthetic process, monitoring batch-to-batch consistency, and identifying potential sources of instability or degradation in peptide drug substances.
Peptide stability studies: Octreotide Impurity 4 provides a valuable tool for conducting forced degradation and stability studies on peptide-based pharmaceuticals. By spiking samples with known quantities of the impurity, researchers can evaluate the propensity of octreotide to form specific degradants under various stress conditions, such as heat, light, pH, or oxidative environments. These studies inform formulation strategies, storage recommendations, and shelf-life assessments by elucidating degradation pathways and the kinetics of impurity formation.
Reference standard for validation: In the context of pharmaceutical quality assurance, Octreotide Impurity 4 functions as a critical reference standard for validating analytical procedures used in the detection and quantification of impurities. Its well-defined structure and properties allow laboratories to calibrate instrumentation, assess method specificity and sensitivity, and ensure the reproducibility of impurity measurements. This contributes to the establishment of reliable quality control protocols for peptide-based drug substances and intermediates.
Peptide synthesis process optimization: Research involving Octreotide Impurity 4 aids in the investigation and refinement of solid-phase peptide synthesis (SPPS) and purification techniques. By tracking the formation of specific impurities, scientists can pinpoint process steps that contribute to undesired byproducts, enabling targeted improvements in synthetic efficiency and product purity. Such insights drive advances in peptide manufacturing processes, ultimately supporting the production of higher-quality research and pharmaceutical peptides.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More